ADMA Biologics: Feeling Bullish After Encouraging Q2 Earnings Report
E4C/E+ via Getty Images
ADMA Biologics (ADMA) recently reported their Q2 results with a beat on EPS and revenue. ADMA continues to make progress on all fronts despite the COVID-19 headwinds. The company has reported quarter-over-quarter revenue growth with…
